Applications of synchrotron X-rays to radiotherapy

被引:69
作者
Blattmann, H [1 ]
Gebbers, JO
Bräuer-Krisch, E
Bravin, A
Le Duc, G
Burkard, W
Di Michiel, M
Djonov, V
Slatkin, DN
Stepanek, J
Laissue, JA
机构
[1] Univ Bern, Inst Pathol, CH-3000 Bern, Switzerland
[2] Kantonsspital, Inst Pathol, Luzern, Switzerland
[3] ESRF, Grenoble, France
[4] Paul Scherrer Inst, CH-5232 Villigen, Switzerland
[5] Univ Bern, Inst Anat, CH-3000 Bern, Switzerland
关键词
photon activation therapy; tomotherapy; microbeam radiation therapy; radiosurgery; CAM; synchrotron X-rays;
D O I
10.1016/j.nima.2005.03.060
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Radiotherapy is among the most useful treatments of cancer. Penetrating radiation (ionizing particles or bremsstrahlung photons) is aimed toward the tumor-bearing target, gradually delivering as high radiation to it as is usefully suppressive of tumor growth, yet tolerated by normal vital tissues inevitably irradiated with the tumor. The high collimation and dose rate of synchrotron X-ray beams, even when monochromatized, favor radiotherapy. Photon activation therapy, tomotherapy, microbeam radiation therapy, and radiosurgery mediated by synchrotron wigglers are conceptually promising for difficult tumors. Radiotherapy of malignant brain tumors in rats has been encouraging, but suitable beam lines exist at only a few research facilities and much basic work must be done before the promise of synchrotron-based radiotherapy can be realized clinically. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 22 条
[1]   Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent:: First trial on rats bearing F98 gliomas [J].
Adam, JF ;
Elleaume, H ;
Joubert, A ;
Biston, MC ;
Charvet, AM ;
Balosso, J ;
Le Bas, JF ;
Estève, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05) :1413-1426
[2]   Cure of fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays [J].
Biston, MC ;
Joubert, A ;
Adam, JF ;
Elleaume, H ;
Bohic, S ;
Charvet, AM ;
Estève, F ;
Foray, N ;
Balosso, J .
CANCER RESEARCH, 2004, 64 (07) :2317-2323
[3]   MOSFET dosimetry for microbeam radiation therapy at the European Synchrotron Radiation Facility [J].
Bräuer-Krisch, E ;
Bravin, A ;
Lerch, M ;
Rosenfeld, A ;
Stepanek, J ;
Di Michiel, M ;
Laissue, JA .
MEDICAL PHYSICS, 2003, 30 (04) :583-589
[4]  
Corde S, 2002, RADIAT RES, V158, P763, DOI 10.1667/0033-7587(2002)158[0763:LOCDEA]2.0.CO
[5]  
2
[6]  
Dilmanian FA, 2003, RADIAT RES, V159, P632, DOI 10.1667/0033-7587(2003)159[0632:MECHTE]2.0.CO
[7]  
2
[8]  
Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26
[9]  
Dilmanian FA, 2001, CELL MOL BIOL, V47, P485
[10]   Enhanced radio sensitivity with iodinated contrast agents using monochromatic synchrotron X-rays on human cancerous cells [J].
Estève, F ;
Corde, S ;
Elleaume, H ;
Adam, JF ;
Joubert, A ;
Charvet, AM ;
Biston, MC ;
Balosso, J ;
Le Bas, JF .
ACADEMIC RADIOLOGY, 2002, 9 :S540-S543